The Bio Report – Podcast: Boosting the Power of Dendritic Cancer Vaccines

SNO 2024 Presentation: DOC1021 Cell-Based Vaccination as Adjuvant Therapy for Glioblastoma: Phase I Clinical Trial Analysis

Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer

Company also names Deancy Okoebor Director of Clinical Operations and Eva Highberg Schumann Project Coordinator as it prepares for a Phase 2 trial of its unique dendritic cell vaccine for glioblastoma HOUSTON–(November 18, 2024)–Diakonos Oncology Corp., a clinical stage immuno-oncology company, announced today that Laura Aguilar, M.D., Ph.D., has been appointed Chief Medical Officer. Dr. Aguilar, a […]

SITC 2024 Poster: Vaccination by Homologous Antigenic Loading as Adjuvant Therapy for Glioblastoma: Correlation of Immune Response and Early Efficacy Signal with Vaccine Cell Gene Signature